ScreenPoint Transpara
Save to shortlistLast reviewed Nov 11, 2026 against the sources listed on this page · How we review
At a glance
Transpara is an FDA-cleared breast AI system that supports radiologists reading 2D mammography and 3D tomosynthesis by detecting suspicious calcifications and soft-tissue lesions and providing a…
- FDA:
- 510(k) K260898 +4 more
- Epic:
- Not on record
- Named users:
- 5 named in public reports
- Published study:
- Yes, linked below
Description
Transpara is an FDA-cleared breast AI system that supports radiologists reading 2D mammography and 3D tomosynthesis by detecting suspicious calcifications and soft-tissue lesions and providing a Transpara Score that reflects the likelihood of malignancy. It is validated for concurrent reading, second reading and reader-workload triage, and is deployed in screening programs across Europe and the US.
Quick answers
Answered only from the sourced records on this page. Questions we can't answer from the record are left out. How we review
- Is ScreenPoint Transpara FDA cleared?
- The public FDA database has 5 records that our team matched to ScreenPoint Transpara. The most recent is 510(k) K260898 (Transpara (2.1.0)), decided Aug 2026. Check that the cleared use matches how you plan to use it.FDA record K260898
- Which health systems use ScreenPoint Transpara?
- Linked public reports name 5 organizations: Riverside Health System, Fairfax Radiology, Johns Hopkins Medicine and 2 more. "Who's using this" below lists them all, plus any the maker reports. Ask the vendor for a reference at an organization like yours.Riverside Health System (Riverside Health System) Fairfax Radiology (PR Newswire) Johns Hopkins Medicine (ScreenPoint Medical)
- Is there published research on ScreenPoint Transpara?
- Yes, this listing links a study (prospective / randomized study). Check whether the patients and setting in the study look like yours.Read the study
Security & contracting
The maker has not reported these details yet. Ask the vendor directly during evaluation.
- Workflow stage
- Not reported
- Integrations
- Not reported
- Data inputs
- Not reported
- Deployment
- Not reported
- Signs a BAA
- Not reported
- SOC 2 report
- Not reported
- HITRUST
- Not reported
- Evidence type
- Prospective / randomized study
Readiness details are self-reported by the maker and are not checked by Clinical Intelligence Foundry. Evidence type describes the kind of study or document the listing links to; it is not a rating or endorsement. Confirm compliance documents with the vendor before purchase.
Who's using this
5 organizationsOrganizations named in public announcements or by the developer. Inclusion is not an endorsement.
Riverside Health System
“Riverside to use AI to assist in reading mammograms” — Riverside Health System, Sep 2023Johns Hopkins Medicine
“ScreenPoint deploys Transpara at Johns Hopkins” — ScreenPoint Medical, Mar 2024Capital Region of Denmark (Copenhagen)
“Transpara to help Danish radiologists reduce screening backlog” — PR Newswire, Nov 2021
Last checked Nov 9, 2026. Spot an error? Let us know through the discussion below.
Get weekly updates for Oncology
Up to 5 new items a week: new tools, FDA decisions and studies. Newest first, never ranked. Confirm by email, unsubscribe any time.
Sources
This listing links to primary sources. Follow the links below to check details directly with the developer, regulator or publication.
Website Research PaperFDA database records
- K260898 · 510(k) · Aug 2026Transpara (2.1.0)
- K241831 · 510(k) · Nov 2024Transpara (2.1.0)
- K232096 · 510(k) · Dec 2023Transpara Density 1.0.0
- K221347 · 510(k) · Aug 2022Transpara 1.7.2
- K210404 · 510(k) · Jun 2021Transpara 1.7.0
Matched by our team from the public FDA database; checked Nov 10, 2026.
History (11)Show
Dated events on this listing's public record, newest first.
- Sep 13, 2026
Added to CIFoundry
- Aug 14, 2026
FDA 510(k) K260898 decision datesource
- Mar 19, 2026
News report names Middlesex Hospital as a user (CHEFA)source
- Nov 25, 2024
FDA 510(k) K241831 decision datesource
- Mar 12, 2024
News report names Johns Hopkins Medicine as a user (ScreenPoint Medical)source
- Dec 11, 2023
FDA 510(k) K232096 decision datesource
- Sep 25, 2023
News report names Riverside Health System as a user (Riverside Health System)source
- May 4, 2023
News report names Fairfax Radiology as a user (PR Newswire)source
- Aug 3, 2022
FDA 510(k) K221347 decision datesource
- Nov 9, 2021
News report names Capital Region of Denmark (Copenhagen) as a user (PR Newswire)source
- Jun 2, 2021
FDA 510(k) K210404 decision datesource
Developer
ScreenPoint Medical
ScreenPoint Medical B.V.
Evaluating this tool?
Get a printable packet for your committee: what the public record shows, the gaps to raise with the vendor, and the questions for this kind of tool.
Prepare evaluation packetChecklist for your role: Admin · Physician · IT · Compliance
Compare similar tools →